Oncaspar
FDA Approves Lymphoseek to Locate Lymph Nodes »
"The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing "...
Read the FDA Approves Lymphoseek to Locate Lymph Nodes article »
Oncaspar
PATIENT INFORMATION
Serious Allergic Reactions
Patients should be informed of the possibility of serious allergic reactions. including anaphylaxis, and to immediately report any swellings or difficulty breathing.
Thrombosis
Patients should be advised to immediately report any severe headache. Arm or leg swelling, acute shortness of breath, and chest pain also should be reported immediately.
Pancreatitis
Patients should be advised to immediately report any severe abdominal pain.
Glucose Intolerance
Patients should be advised to report excessive thirst or any increase in the volume or frequency of urination.
Last reviewed on RxList: 3/2/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Oncaspar Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.
Updated & New
